APA (7th ed.) Citation

Charef, O., Mlayah, Z., Bnouni, Y., Mabrouk, N., Boufrikha, W., Nader, S., . . . Laatiri, A. (2023). PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA. Wiley.

Chicago Style (17th ed.) Citation

Charef, Ons, Zaineb Mlayah, Yasmine Bnouni, Nada Mabrouk, Wiem Boufrikha, Slama Nader, Sarra Boukhriss, and Adnene Laatiri. PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA. Wiley, 2023.

MLA (9th ed.) Citation

Charef, Ons, et al. PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA. Wiley, 2023.